# US 2021/0280270 A1 · Method to determine if a circulating fetal cell isolated from a pregnant mother is from either the current or a historical pregnancy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0280270 A1
- Document ID: US20210280270A1
- Status: Published application
- Kind: A1
- Application number: 17/274,155
- Filed: 2019-09-06
- Published: 2021-09-09
- Earliest claimed: 2018-09-07
- Assignees: Illumina, Inc.; Illumina Cambridge Limited
- Applicants: Illumina, Inc.; Illumina Cambridge Limited
- Inventors: Andrew Craig; Fiona Kaper
- Web page: https://patentgrep.com/patent/US20210280270A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G06N 7/01: Probabilistic graphical models, e.g. probabilistic networks
- G06N 20/00: Machine learning
- G16B 20/10: Ploidy or copy number detection
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 40/20: Supervised data analysis
- G16H 50/30: for calculating health indices; for individual health risk assessment
- C12Q 2600/156: Polymorphic or mutational markers
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Disclosed are methods for determining a genetic origin of fetal cellular DNA obtained from a pregnant female who is carrying a fetus in a current pregnancy. Methods are also disclosed for using the fetal cellular DNA and fetal cell-free DNA (cfDNA) to determine fetal genetic conditions such as copy number variations. The methods disclosed uses a probabilistic model to determine fetal cellular DNA origin based on alleles observed at informative genetic marker of the fetal cellular DNA. Systems and computer program products for performing the methods are also disclosed.

## Claims

### Claim 1

A method of determining a genetic origin of fetal cellular DNA obtained from a pregnant female who is carrying a fetus in a current pregnancy, the method comprising:
(a) receiving a genotype of the fetus in the current pregnancy, wherein the genotype of the fetus in the current pregnancy comprises one or more alleles for each genetic marker of a plurality of genetic markers, where each genetic marker represents a polymorphism at a unique genomic locus;
(b) receiving a genotype of the pregnant female, wherein the genotype of the pregnant female comprises one or more alleles for each genetic marker of the plurality of the genetic markers;
(c) identifying, from the genotype of the pregnant female and from the genotype of fetus in the current pregnancy, a set of informative genetic markers, wherein each informative genetic marker of the set of informative genetic markers is homozygous in the pregnant female and is heterozygous in the fetus in the current pregnancy;
(d) for the fetal cellular DNA obtained from the pregnant female, determining one or more alleles at each informative genetic marker of the set of informative genetic markers, wherein the fetal cellular DNA originates from the fetus in the current pregnancy or a fetus in a historical pregnancy;
(e) providing as input to a probabilistic model the one or more alleles at each informative genetic marker of the fetal cellular DNA obtained from the pregnant female;
(f) obtaining, as output of the probabilistic model, a probability that the fetal cellular DNA obtained from the pregnant female originates from a fetus in the current pregnancy; and
(g) determining, from the output of the probabilistic model, whether the fetal cellular DNA originates from the fetus in the current pregnancy,
wherein at least (e) and (f) are performed by a computer comprising a processor and memory.

### Claim 2 (depends on 1)

The method of claim 1, wherein (f) comprises: obtaining, as output of the probabilistic model, probabilities of three scenarios: the fetal cellular DNA obtained from the pregnant female originates from a fetus in (1) the current pregnancy, (2) the historical pregnancy and having a same father as the fetus in the current pregnancy, and (3) the historical pregnancy and having a different father from the fetus in the current pregnancy.

### Claim 3 (depends on 2)

The method of claim 2, wherein (g) comprises: determining whether the fetal cellular DNA originates from the fetus in (1) the current pregnancy, (2) the historical pregnancy and having a same father as the fetus in current pregnancy, or (3) the historical pregnancy and having a different father as the fetus in the current pregnancy.

### Claim 4 (depends on 2)

The method of claim 2, wherein (e) comprises providing as input to the probabilistic model a number of shared genetic markers, wherein a shared genetic marker is a genetic marker in the informative genetic markers for which the fetal cellular DNA obtained from the pregnant female and the fetus in the current pregnancy have same alleles.

### Claim 5 (depends on 4)

The method of claim 4, wherein the probabilistic model calculates the probabilities of the three scenarios given the number of shared genetic markers based on probabilities of the number of shared genetic markers given the three scenarios.

### Claim 6 (depends on 5)

The method of claim 5, wherein the probabilistic model calculates the probabilities of the three scenarios given the number of shared genetic markers as follows:
p
⁡
(
s
i
❘
k
)
=
p
⁡
(
k
❘
s
i
)
⁢
p
⁡
(
s
i
)
p
⁡
(
k
)
wherein
p(si|k) is a probability of scenario i, or si, given the number of shared genetic markers, or k,
p(k|si) is a probability of the number of shared genetic markers given scenario i,
p(si) is an overall probability of scenario i, and
p(k) is an overall probability of the number of shared genetic markers.

### Claim 7 (depends on 5, 6)

The method of any of claims 5-6, wherein, for each scenario, the probabilistic model simulates the number of shared genetic markers given scenario i, or k|si, as a random variable drawn from a beta-binomial distribution.

### Claim 8 (depends on 7)

The method of claim 7, wherein the probabilistic model simulates the number of shared genetic markers given scenario i, or k|si as a random variable drawn from a binomial distribution with a success rate μi, and μi is a random variable drawn from a beta distribution with hyperparameters ai and bi; namely, k|si˜BN(n,μi) and μi˜Beta(ai,bi), n being the number of informative genetic markers in the set of informative genetic markers.

### Claim 9 (depends on 8)

The method of claim 8, wherein the probability of the number of shared genetic markers given scenario i is calculated from the following likelihood function:
p
⁡
(
k
❘
s
i
)
=
(
n
k
)
⁢
B
⁡
(
k
+
a
i
,
n
-
k
+
b
i
)
B
⁡
(
a
i
,
b
i
)
wherein
n is the number of informative genetic markers,
k is the number of shared genetic markers,
β( ) is a beta function, and
ai and bi are the hyperparameters of the beta distribution for scenario i.

### Claim 10 (depends on 8, 9)

The method of any of claims 8-9, wherein
ai=μi*w
bi=(1−μi)*w
wherein w is a parameter representing a number of pseudo counts or observations.

### Claim 11 (depends on 8, 9, 10)

The method of any of claims 8-10, wherein μi is set to correspond to an expected proportion of shared genetic markers among the set of informative genetic markers in scenario i.

### Claim 12 (depends on 11)

The method of claim 11, wherein the probabilistic model calculates μ1, the expected proportion of shared genetic markers for scenario (1), as follows:
μ
1
=
1
-
1
n
+
1
wherein n is the number of informative genetic markers.

### Claim 13 (depends on 11)

The method of claim 11, wherein the probabilistic model calculates μ2, the expected proportion of shared genetic markers for scenario (2), as follows,
μ
2
=
1
n
⁢
∑
j
=
1
n
⁢
⁢
[
p
j
+
1
2
⁢
(
1
-
p
j
)
]
wherein pi is a population frequency of a hetero-allele at the jth marker, the hetero-allele being an allele at an informative genetic marker found in the fetus in the current pregnancy but not in the pregnant female.

### Claim 14 (depends on 11)

The method of claim 11, wherein the probabilistic model calculates μ3, the expected proportion of shared genetic markers for scenario (3), as follows:
μ
3
=
1
n
⁢
∑
j
=
1
n
⁢
⁢
p
j
wherein
pj is a population frequency of a hetero-allele at the jth marker.

### Claim 15 (depends on 2)

The method of claim 2, further comprising providing prior probabilities of the three scenarios to the probabilistic model, wherein the probabilistic model provides posterior probabilities of the three scenarios based on the prior probabilities of the three scenarios, as well as on the alleles at the one or more markers.

### Claim 16

The method of any of the preceding claims, further comprising:
obtaining cell free DNA (“cfDNA”) from the pregnant female; and
genotyping the cfDNA from the pregnant female to produce (i) the genotype of the fetus in the current pregnancy, and (ii) the genotype of the pregnant female.

### Claim 17

The method of any of the preceding claims, further comprising:
obtaining at least one cell of the pregnant female;
genotyping cellular DNA obtained from the at least one cell of the pregnant female to produce the genotype of the pregnant female;
obtaining cfDNA from the pregnant female; and
genotyping the cfDNA from the pregnant female to produce the genotype of the fetus in the current pregnancy.

### Claim 18

The method of any of the preceding claims, wherein the fetal cellular DNA is from a circulating fetal cell (“cFC”) circulating in the pregnant female.

### Claim 19 (depends on 18)

The method of claim 18, further comprising determining a genetic origin of the cFC.

### Claim 20

The method of any of the preceding claims, wherein the fetal cellular DNA is determined to originate from the fetus in the current pregnancy, and the method further comprises analyzing the fetal cellular DNA to determine whether the fetus in the current pregnancy has a genetic abnormality.

### Claim 21 (depends on 20)

The method of claim 20, wherein the genetic abnormality is an aneuploidy.

### Claim 22 (depends on 20)

The method of claim 20, wherein the analyzing the fetal cellular DNA comprises using both information from the fetal cellular DNA and information from fetal cfDNA obtained from the pregnant female during the current pregnancy to determine whether the fetus in the current pregnancy has the genetic abnormality.

### Claim 23

The method of any of the preceding claims, wherein each informative genetic marker is biallelic.

### Claim 24

A computer program product comprising a non-transitory machine readable medium storing program code that, when executed by one or more processors of a computer system, causes the computer system to implement a method of determining the genetic origin of fetal cellular DNA obtained from a pregnant female who is carrying a fetus in a current pregnancy, said program code comprising:
(a) code for determining, for the fetal cellular DNA obtained from the pregnant female, one or more alleles at each informative genetic marker of a set of informative genetic markers,
wherein
each informative genetic marker represents a polymorphism at a unique genomic locus,
each informative genetic marker is homozygous in the pregnant female and is heterozygous in the fetus in the current pregnancy, and
the fetal cellular DNA originates from the fetus in the current pregnancy or a fetus in a historical pregnancy; and
(b) code for providing as input to a probabilistic model the one or more alleles at each informative genetic marker of the fetal cellular DNA obtained from the pregnant female;
(c) code for obtaining as output of the probabilistic model probabilities of three scenarios: the fetal cellular DNA obtained from the pregnant female originating from a fetus in (1) the current pregnancy, (2) the historical pregnancy and having a same father as the fetus in the current pregnancy, and (3) the historical pregnancy and having a different father from the fetus in the current pregnancy; and
(d) code for determining, from the output of the probabilistic model, whether the fetal cellular DNA originates from the fetus in (1) the current pregnancy.

### Claim 25

A computer system, comprising:
one or more processors;
system memory; and
one or more computer-readable storage media having stored thereon computer-executable instructions that, when executed by the one or more processors, cause the computer system to implement a method of determining the genetic origin of fetal cellular DNA obtained from a pregnant female who is carrying a fetus in a current pregnancy, the method comprising:
(a) determining, for the fetal cellular DNA obtained from the pregnant female, one or more alleles at each informative genetic marker of to set of informative genetic markers,
wherein
each informative genetic marker represents a polymorphism at a unique genomic locus,
each informative genetic marker is homozygous in the pregnant female and is heterozygous in the fetus in the current pregnancy, and
the fetal cellular DNA originates from the fetus in the current pregnancy or a fetus in a historical pregnancy; and
(b) providing as input to a probabilistic model the one or more alleles at each informative genetic marker of the fetal cellular DNA obtained from the pregnant female;
(c) obtaining as output of the probabilistic model probabilities of three scenarios: the fetal cellular DNA obtained from the pregnant female originating from a fetus in (1) the current pregnancy, (2) the historical pregnancy and having a same father as the fetus in the current pregnancy, and (3) the historical pregnancy and having a different father from the fetus in the current pregnancy; and
(d) determining, from the output of the probabilistic model, whether the fetal cellular DNA originates from the fetus in (1) the current pregnancy.

### Claim 26

A method for matching pairs of character strings using probabilistic modeling and computer simulation, wherein two character strings in any pair have a same number of characters, the method comprising:
(a) receiving a first pair of character strings;
(b) receiving a fifth pair of character strings;
(c) identifying a set of informative character positions in both the first pair of character strings and the fifth pair of character strings, wherein each informative character position of the set of informative character positions (i) represents a unique position in each character string, (ii) has one or both of two different characters in any pair of character strings, (iii) has only one character of said two different characters in the fifth pair of character strings, and (iv) has both characters of said two different characters in the first pair of character strings;
(d) determining, for a fourth pair of character strings, characters at the set of informative character positions;
(e) providing, as input to a probabilistic model, the characters at the set of informative character positions of the fourth pair of character strings, wherein the probabilistic model was trained using a training dataset comprising pairs of character strings;
(f) obtaining, as output of the probabilistic model, a probability that the fourth pair of character strings matches the first pair of character strings, wherein two different character strings of each pair of character strings have a same length, each informative character position has a corresponding position on each character strings, the first pair of character strings is obtainable by recombining the fifth pair of character strings with a sixth pair of pair of character strings; and
(g) determining, from the output of the probabilistic model, whether the fourth pair of character strings matches the first pair of character strings,
wherein at least (e) and (f) are performed by a computer system comprising a processor and memory.

### Claim 27 (depends on 26)

The method of claim 26, wherein (f) comprises: obtaining probabilities of three scenarios: the fourth pair of character strings matches the first, a second, and a third pair of character strings, wherein the second pair of character strings is obtainable by recombining the fifth pair of character strings with the sixth pair of character strings, and the third pair of character strings is obtainable by recombining the fifth pair of character strings with a seventh pair of character strings.

### Claim 28 (depends on 27)

The method of claim 27, wherein (g) comprises determining, from the output of the probabilistic model, whether the fourth pair of character strings matches the first, second, or third pair of character strings.
